European Society of Cardiology 2011

Lower risk of stent thrombosis and restenosis in New Generation drug-eluting stents - Giovanna Sarno, Uppsala University, Sweden	Assessment of myocardial viability: Integration of coronary anatomy, function, perfusion and metabolism - Antti Saraste, Turku University Hospital, Finland	One-Year Follow-up Data of a 2-Year Study in Patients Initially Hospitalized with Acute Coronary Syndrome - Katsumi Miyauchi, Juntendo University School of Medicine, Tokyo, Japan
Smokeless tobacco (Snus) and Mortality after Myocardial Infarction - Gabriel Arefalk, Uppsala University Hospital , Sweden	Smoking, obesity and mortality in middle-aged people - Prof. G.Nilsson , Uppsala university, Sweden	Carotid Atherosclerosis - Natural History and Complications, Prof. Pavel Poredos, Ljubljana, Slovenia
Antiplatelet and anticoagulant treatment - Prof. Robert Storey, Sheffield, UK	Invasive Coronary Imaging in Daily Practice: Intravascular Ultrasound to Optimize Percutaneous Coronary Interventions Results, Sao Paulo	Smoking Relapse and Mortality after ACS, Rome, Italy
EAE Position Paper on Pocket Size Imaging Devices - Rosa Sicari, Pisa, Italy	Featured research on genetic aspects of cardiac arrhythmias - Peter Schwartz, Pavia, Italy	Difficult echography in an adult patient previously unknown to have congenital heart disease - Laurence Iserin, Paris, France
Influence of Mitral Regurgitation on Survival in the Surgical Treatment for Ischemic Heart Failure, Alec Vahanian, Paris ,France	Pathobiological changes in PAH - Marc Humbert, Clamart, France	Influence of gender and BMPR2 mutation type on clinical phenotypes of heritable PAH
Can we cure resistant hypertension? - Stephane Laurent, Paris France	A dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG pattern - Darouna Kattynarath, Paris ,France	A rare variant in MYH6 confers high risk of sick sinus syndrome - Hilma Holm, Paris, France
European Cardiac Resynchronization Therapy (CRT) Survey 1 year Follow-up Results - Nigussie Bogale, Stavanger University Hospital, Norway	Myocardial Infarction 2050, Valentin Fuster, Mount Sinai School of Medicine, New York	Imaging Pericardial Diseases: Update 2011, Partho Sengupta, New York
How to Manage Cardiac Resynchronization Therapy in Atrial Fibrillation Patients, Daniel Gras, Nantes, France	"Old Therapies":How was myocardial infarction management in 1970?, Gunter Breithardt, Universitatsklinkum Munster, Germany	Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension, Instituto Auxologico Italiano,Milano, Italy
Is there a role for CT/Myocardial Magnetic Resonance imaging in aortic stenosis, University of Messina, Italy	Probing prognosis in heart failure, Daniel Wagner, Luxembourg	State of the Art - Can We Cure Resistant Hypertension, Thomas Lambert, Linz, Austria
Future Interventional Therapies and New Devices for Myocardial Infarction in 2050, Frans Van de Werf, University Hospital, Leuven, Belgium	EAE recommendations about the use of echo in Emergency Department - Prof.Dr. Andreas Hagendorff, University of Leipzig	The use of cardiac resynchronization therapy outside current guidelines - R.J. van Bommel , Leiden University Medical Center
Essential role of CD4 T cells in Angiotensin II-induced atherosclerosis and vulnerable plaque development - Maxime Pellegrin - Service of Angiology, Lausanne, Switzerland	Long term clinical outcomes and duration of dual antiplatelet therapy after drug-eluting stent implantation: landmark analyses from Credo-Kyoto cohort-2 registry - T.Tada, Kyoto University Hospital, Japan	Non-ST-elevation-ACS - Invasive Management, Dariusz Dudek, Krakow, Poland
Persistent Smoking in High-Risk Patients - The Reality in Clinical Practice and How to Improve - Dr. Kornelia Kotseva, Imperial College London	CMR - assessing myocardial viability, Eike Nagel, Kings College of London	New Therapy for Atherosclerosis Targeting FRb- expressing Macrophages, Yuko Furusho, Kagoshima University, Japan
Global two-dimensional strain as a novel parameter of myocardial fibrosis, and the assessment of risk for major cardiac events in patients with hypertrophic cardiomyopathy, Makoto Saito, Ehime Prefectural Central Hospital, Japan	Sodium channelopathies in the developing heart: a key to understanding adult arrhythmogenesis - Dr. Amelia Aranega Jimenez, University of Jaen, Spain	Serial measurement of cardiac troponin T using a highly sensitive assay in patient with chronic HF: Results from two large randomised clinical trials. Italy and USA
Calcium channelopathies: current appraisal and future hopes - Silvia G Priori, Molecular Cardiology, Pavia, Italy	Early aggressive versus initially conservative strategy in elderly patients with non-ST-elevation ACS:The Italian Elderly ACS randomised trial	Role of 2D and 3D in Aortic stenosis - Tips and Tricks - Shantanu Sengupta, Nagpur, India
Strategies for smoking cessation - evidence from trials - Prof. David Wood, Imperial College London, UK	Biventricular Pacing Superior to Right Ventricular Pacing in Bradycardia Patients with Preserved Systolic Function: Two-year Results of PACE - Cheuk-Man Yu,The Chinese University of Hong Kong, China	Right ventricular adaptation to pressure load in mice is improved after blockade of Calcineurin activation, Groningen
Is clopidogrel discontinuation following ACS hospitalisation associated with a higher risk of death and myocardial infarction? R.Boggon, Edinburgh	Computed Tomography - Stephen Achenbach, University of GieBen , Germany	Rationale for Carotid Artery Stenting - Prof. Marco Roffi, University Hospital, Geneva - Switzerland
The very latest on carotid stenting: Rationale for Surgery, P. Bergeron, Hopital Prive Residence du Parc, France	Effector memory T cells are related to the atherosclerotic process in humans and murine models - Enrico Ammirati,Florence, Italy	Current indications for resynchronisation therapy - Panos E.Vardas Heraclion University Hospital, Crete, Greece
Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography substudy	SHIFT - Discussion	Expression profiles of miRNAs in peripheral blood monocytes in different stages of atherosclerosis development in humans, Katharina Daum, University Hospital of Giessen and Marburg
Tobacco use: No smoke without fire - Charlotta Pisinger, Denmark	The very latest on carotid stenting: When to intervene - Alberto Cremonesi, Maria Cecilia Hospital, Cotignola, Italy	Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy: a multi-modality study - The University of Queensland, Brisbane
Conformation of Sustainability of Hemodynamic Response to Baroreflex Activation Therapy in Resistant hypertension, Abraham Kroon, Chicago, USA	Epicardial Ft Volume is Related to Severe Stenosis and High-Risk Plaque Featured assessed by Coronary CTA, California, USA	FRANCE 2 - Martin Gilard - University of Brest, France
Old Challenges in Interventional Cardiology, Elliott Antman, Boston,USA	Baseline difference in transcriptional patterns between PAH patients and normal volunteers, Silvia Cantoni, University of Bologna, Italy	Linking pitx2 insufficiency to atrial fibrillation - Paulus Kirchhof, University of Birmingham
OCT in Acute Coronary Syndromes - Giulio Guagliumi, Italy	Reduced incidence of STEMI in the first 3 years after inroduction of a public smoking ban in canton Ticino - M. Di Valentino - Bellinzona, Switzerland	Imaging pericardial disease:Invasive diagnostic procedures,Arsen Ristic, Belgrade, Serbia
EAE/ASE recommendation about Echo Assessment of Cardiac Mechanics - Jens-Uwe Voigt, Leuven, Belgium	Impact of CYP2C19*3 Polymorphism on Platelet Reactivity and Adverse Clinical Events in Patients with Acute Myocardial Infarction,Young-Hoon Jeong, Korea	TGF is linked to abnormal collagen turnover leading to impaired myocardial derormation in untreated hypertensives, University of Athens, Greece
Brugada Syndrome:A development perspective,Carol Ann Remme, University of Amsterdam, The Netherlands	Mitral Regurgitation - Look for the mechanism - Berto Bouma, Amsterdam, The Netherlands	Randomised Evaluation of Secondary Prevention by Outpatient Nurse Specialists - Ron Peters, University of Amsterdam, The Netherlands
Primary Percutaneous Coronary Intervention as a national reperfusion strategy - Christian Terkelsen, Skejby University Hospital,County of Aarhus,Denmark	ESC Guidelines on the diagnosis and treatment of PAD: Multisite Disease, Frankfurt, Germany	ESC Guidelines on the diagnosis and treatment of PAD: Lower extremity artery disease - Erich Minar, Medical University Vienna
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Mesenteric and Renal Artery Disease, Thomas Zeller,MD - Herz-Zentrum Bad Krozingen, Germany	Extracranial carotid , vertebral and upper extremity artery disease - Mark van Sambeek, MD, Catharina Hospital Eindhoven, The Netherlands	The Truly low stroke risk patient with AF: defining the population and what to do post-ablation - Laurent Fauchier, Trousseau, France
Antithrombotic treatment in ACS: What do the guidelines say? - Nicolas Danchin, Paris, France	Tailored antithrombotic therapy in NSTEMI - Philippe Gabriel Steg, Universite Paris, France	Comparison of Three-year Outcome after PCI and CABG in Triple Vessel CAD - Hiroki Shiomi, Kyoto University, Japan
One-Year Clinical and Angiographic Outcomes from the RESET Trial - Takeshi Kimura,MD - Kyoto University, Japan	EMPHASIS-HF:The effect of eplerenone versus placebo on cardiovascular mortality or HF hospitalization in subjects with NYHA class II chronic systolic HF - Piotr Ponikowski, Clinical Military Hospital, Wroclaw, Poland	Discussant - ECOST - JC Daubert, Universite de Rennes 1, France
Safety and Effectiveness of ICD Follow - up using Remote Monitoring - Salem Kacet, Universite Lille 2 , Droit et Sante, France	What should the general cardiologist know about Marfan - Syndrome - H. Kaemmerer - Deutsches Herzzentrum Munchen	Management of the cyanotic patient - Dr Lorna Swan - Royal Brompton and Harefield
Does CKD modify the advice of the HF guidelines? - Martin Cowie - Imperial College, London	New antithrombotic therapies: revisiting stroke prevention in atrial fibrillation - Lars Wallentin - Uppsala Clinical Research Centre (UCR), Uppsala	Heart Failure Trials: Heart Rate as a Target - Jeffrey S. Border - State University of New Yorke
Relationship between heart rate and health - related quality of life in patient wih CHF.Results from the SHIFT substudy	ESC/EAS Guidelines for the Management of Dyslipidemias - Alberico L. Catapano	ESC Guidelines for the management of ACS in patient presenting without persistent ST - segment elevation
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases	How to use aldosterone blockers? - Faiez Zannad - University Henri Poincare, Nancy, France	Will catheter ablation of AF withstand the test of randomised studies? - Dr. Sabine Ernst - Imperial College, London
ESC Guidelines on the Management of CVD during Pregnancy - Vera Regitz - Zagrosek, (Charite, Berlin)	Telemonitoring in clinical practice - Prof. Friedrich Koehler. MD (Charite, Berlin)	Stroke and bleeding risk assessment in a high risk atrial fibrillation patient who needs a coronary stent - Andrea Rubboli, MD (Bologna, Italy)
One-Year Clinical and Angiographic Outcomes from the RESET - Stephan Windecker - Bern University of Hospital,Switzerland	Does the presence of chronic kidney disease modify the advice of guidelines in the ACS - Doron Zahger, MD - Beer Sheva (Israel)	New developments in the diagnosis of atrial fibrillation - Gerhard Hindricks (University of Leipzig - Heart Center)

Хирургия | MySurgery.bg

ПЪРВИЯТ ВИРТУАЛЕН АСИСТЕНТ ЗА ПОДКРЕПА НА ПАЦИЕНТИ С РАК НА БЕЛИЯ ДРОБ, ХРАНОПРОВОДА, ЛИМФОМА И МЕЗОТЕЛИОМА.